Crovalimab
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Crovalimab, covering 2022-12-15 to 2026-04-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors [Phase 3]